{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T19:15:25Z","timestamp":1785179725249,"version":"3.55.0"},"reference-count":167,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016045","name":"University of Central Punjab","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001427","name":"All India Council for Technical Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001427","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bmc.2024.117933","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T15:35:59Z","timestamp":1727969759000},"page":"117933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Carbonic anhydrases: Moiety appended derivatives, medicinal and pharmacological implications"],"prefix":"10.1016","volume":"114","author":[{"given":"Aashish","family":"Jaitak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushi","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Kounder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4004-6241","authenticated-orcid":false,"given":"Vikramdeep","family":"Monga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2024.117933_b0005","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/14756366.2014.910202","article-title":"An overview of the alpha-, beta-and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria?","volume":"30","author":"Capasso","year":"2015","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jinorgbio.2011.11.017","article-title":"(In) organic anions as carbonic anhydrase inhibitors","volume":"111","author":"De Simone","year":"2012","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.bmc.2024.117933_b0015","doi-asserted-by":"crossref","first-page":"15184","DOI":"10.1073\/pnas.96.26.15184","article-title":"Carbonic anhydrase is an ancient enzyme widespread in prokaryotes","volume":"96","author":"Smith","year":"1999","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2024.117933_b0020","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2024.117933_b0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature06636","article-title":"Structure and metal exchange in the cadmium carbonic anhydrase of marine diatoms","volume":"452","author":"Xu","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2024.117933_b0030","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jmb.2008.11.037","article-title":"Structure and inhibition of the CO2-sensing carbonic anhydrase Can2 from the pathogenic fungus Cryptococcus neoformans","volume":"385","author":"Schlicker","year":"2009","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bmc.2024.117933_b0035","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0021-9258(18)75831-6","article-title":"The catalysis of the hydration of carbon dioxide and dehydration of carbonic acid by an enzyme isolated from red blood cells","volume":"103","author":"Stadie","year":"1933","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0040","doi-asserted-by":"crossref","first-page":"18782","DOI":"10.1074\/jbc.M414348200","article-title":"Structure and function of carbonic anhydrases from Mycobacterium tuberculosis","volume":"280","author":"Covarrubias","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0045","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3109\/14756366.2013.868599","article-title":"Biochemical characterization of the \u03b4-carbonic anhydrase from the marine diatom Thalassiosira weissflogii, TweCA","volume":"29","author":"Del Prete","year":"2014","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0050","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2024.117933_b0055","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem J"},{"key":"10.1016\/j.bmc.2024.117933_b0060","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1016\/j.bmcl.2014.08.015","article-title":"Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum\u2014the \u03b7-carbonic anhydrases","volume":"24","author":"Del Prete","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.117933_b0065","first-page":"1","article-title":"Carbonic anhydrase and bacterial metabolism: a chance for antibacterial drug discovery","author":"Capasso","year":"2024","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bmc.2024.117933_b0070","doi-asserted-by":"crossref","DOI":"10.2174\/0109298673249553231018070920","article-title":"Advances in the development of carbonic anhydrase inhibitors as new antiprotozoal agents","author":"Ortiz-P\u00e9rez","year":"2024","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0075","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1021\/bi00749a016","article-title":"Plant carbonic anhydrase. Properties and carbon dioxide hydration kinetics","volume":"12","author":"Pocker","year":"1973","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2024.117933_b0080","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1749-6632.1984.tb12340.x","article-title":"Chemical properties, distribution, and physiology of plant and algal carbonic anhydrases","volume":"429","author":"Graham","year":"1984","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.bmc.2024.117933_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1338528","article-title":"Carbonic anhydrase, its inhibitors and vascular function","volume":"11","author":"Garc\u00eda-Llorca","year":"2024","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.bmc.2024.117933_b0090","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/0006-291X(72)90400-7","article-title":"Amino acid sequence of human erythrocyte carbonic anhydrase B","volume":"48","author":"Andersson","year":"1972","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2024.117933_b0095","first-page":"218","article-title":"Purification and properties of bovine erythrocyte carbonic anhydrase","volume":"39","author":"Lindskog","year":"1960","journal-title":"BBA"},{"key":"10.1016\/j.bmc.2024.117933_b0100","first-page":"1","article-title":"Purification and properties of carbonic anhydrase from human erythrocytes","volume":"52","author":"Nyman","year":"1961","journal-title":"BBA"},{"key":"10.1016\/j.bmc.2024.117933_b0105","first-page":"141","article-title":"Amino acid composition of various forms of bovine and human erythrocyte carbonic anhydrase","volume":"85","author":"Nyman","year":"1964","journal-title":"Biochim Biophys Acta (BBA)-Special Sect Enzymol Subj"},{"key":"10.1016\/j.bmc.2024.117933_b0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/metabo8010019","article-title":"Carbonic anhydrases: role in pH control and cancer","volume":"8","author":"Mboge","year":"2018","journal-title":"Metabolites"},{"key":"10.1016\/j.bmc.2024.117933_b0115","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1006\/jmbi.1994.1655","article-title":"Drug-protein interactions: refined structures of three sulfonamide drug complexes of human carbonic anhydrase I enzyme","volume":"243","author":"Chakravarty","year":"1994","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bmc.2024.117933_b0120","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/0022-2836(92)90531-N","article-title":"Structure of native and apo carbonic anhydrase II and structure of some of its anion-ligand complexes","volume":"227","author":"H\u00e5kansson","year":"1992","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bmc.2024.117933_b0125","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1002\/pro.5560071201","article-title":"Structural analysis of inhibitor binding to human carbonic anhydrase II","volume":"7","author":"Boriack-Sjodin","year":"1998","journal-title":"Protein Sci"},{"key":"10.1016\/j.bmc.2024.117933_b0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13065-024-01150-1","article-title":"In silico evaluation of a new compound incorporating 4 (3H)-quinazolinone and sulfonamide as a potential inhibitor of a human carbonic anhydrase","volume":"18","author":"Alkaoud","year":"2024","journal-title":"BMC Chemistry"},{"key":"10.1016\/j.bmc.2024.117933_b0135","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2174\/092986710790979999","article-title":"Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII","volume":"17","author":"Guler","year":"2010","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0140","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.1073\/pnas.161301298","article-title":"Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells","volume":"98","author":"Whittington","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2024.117933_b0145","doi-asserted-by":"crossref","first-page":"12056","DOI":"10.1016\/S0021-9258(18)33676-7","article-title":"Membrane-associated carbonic anhydrase purified from bovine lung","volume":"257","author":"Whitney","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0150","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0022-2836(90)90159-J","article-title":"Occurrence and role ofcis peptide bonds in protein structures","volume":"214","author":"Stewart","year":"1990","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bmc.2024.117933_b0155","doi-asserted-by":"crossref","unstructured":"Stams T, et al., Crystal structure of the secretory form of membrane-associated human carbonic anhydrase IV at 2.8-\u00c5 resolution. Proc Natal Acad Sci 1996; 93(24): 13589\u201313594.","DOI":"10.1073\/pnas.93.24.13589"},{"key":"10.1016\/j.bmc.2024.117933_b0160","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0022-2836(91)90721-H","article-title":"Influence of proline residues on protein conformation","volume":"218","author":"MacArthur","year":"1991","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bmc.2024.117933_b0165","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1432-1033.1993.tb17614.x","article-title":"Importance of the conserved active-site residues Try7, Glu106 and Thr199 for the catalytic function of human carbonic anhydrase II","volume":"211","author":"Liang, z.,","year":"1993","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bmc.2024.117933_b0170","doi-asserted-by":"crossref","first-page":"27458","DOI":"10.1016\/S0021-9258(19)74269-0","article-title":"Structural and functional importance of a conserved hydrogen bond network in human carbonic anhydrase II","volume":"268","author":"Krebs","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0175","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.bpj.2020.08.037","article-title":"Isoform-selective enzyme inhibitors by exploring pocket size according to the lock-and-key principle","volume":"119","author":"Dudutien\u0117","year":"2020","journal-title":"Biophys J"},{"key":"10.1016\/j.bmc.2024.117933_b0180","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3390\/molecules23051045","article-title":"Cancer drug development of carbonic anhydrase inhibitors beyond the active site","volume":"23","author":"Singh","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2024.117933_b0185","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1021\/acs.biochem.6b00243","article-title":"The structure of carbonic anhydrase IX is adapted for low-pH catalysis","volume":"55","author":"Mahon","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2024.117933_b0190","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/14756366.2019.1705293","article-title":"Design, synthesis and biological evaluation of carbohydrate-based sulphonamide derivatives as topical antiglaucoma agents through selective inhibition of carbonic anhydrase II","volume":"35","author":"Hou","year":"2020","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0195","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.seizure.2022.03.024","article-title":"Molecular mechanisms of topiramate and its clinical value in epilepsy","volume":"98","author":"Bai","year":"2022","journal-title":"Seizure"},{"key":"10.1016\/j.bmc.2024.117933_b0200","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/453543","article-title":"Probing the surface of human carbonic anhydrase for clues towards the design of isoform specific inhibitors","volume":"2015","author":"Pinard","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.bmc.2024.117933_b0205","first-page":"3","article-title":"Advances in anti-cancer drug development targeting carbonic anhydrase IX and XII","volume":"5","author":"Mboge","year":"2015","journal-title":"Top Anti-Cancer Res"},{"key":"10.1016\/j.bmc.2024.117933_b0210","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.3390\/molecules20022323","article-title":"Targeting carbonic anhydrase IX activity and expression","volume":"20","author":"Mahon","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2024.117933_b0215","doi-asserted-by":"crossref","first-page":"15789","DOI":"10.1074\/jbc.M110.188524","article-title":"Catalysis and pH control by membrane-associated carbonic anhydrase IX in MDA-MB-231 breast cancer cells","volume":"286","author":"Li","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0220","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.7150\/jca.46902","article-title":"Carbonic anhydrase 4 serves as a clinicopathological biomarker for outcomes and immune infiltration in renal cell carcinoma, lower grade glioma, lung adenocarcinoma and uveal melanoma","volume":"11","author":"Xu","year":"2020","journal-title":"J Cancer"},{"key":"10.1016\/j.bmc.2024.117933_b0225","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0230","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.canlet.2013.01.020","article-title":"Pharmacological inhibition of carbonic anhydrase XII interferes with cell proliferation and induces cell apoptosis in T-cell lymphomas","volume":"333","author":"Lounnas","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bmc.2024.117933_b0235","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ejcb.2010.03.004","article-title":"Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway","volume":"89","author":"Hsieh","year":"2010","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.bmc.2024.117933_b0240","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.eururo.2015.11.033","article-title":"Phase 2 study of lutetium 177\u2013labeled anti\u2013carbonic anhydrase IX monoclonal antibody girentuximab in patients with advanced renal cell carcinoma","volume":"69","author":"Muselaers","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.bmc.2024.117933_b0245","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s00120-004-0609-3","article-title":"Specific monoclonal antibody-based immunotherapy by targeting the RCC-associated antigen carbonic anhydrase-IX G250\/MN","volume":"43","author":"Mulders","year":"2004","journal-title":"Urologe"},{"key":"10.1016\/j.bmc.2024.117933_b0250","article-title":"A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma","volume":"7","author":"Davis","year":"2007","journal-title":"Cancer Immun"},{"key":"10.1016\/j.bmc.2024.117933_b0255","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.bmc.2024.117933_b0260","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1582-4934.2009.00994.x","article-title":"Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer","volume":"14","author":"Chiche","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.bmc.2024.117933_b0265","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bmc.2024.117933_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-015-0278-7","article-title":"New horizons in tumor microenvironment biology: challenges and opportunities","volume":"13","author":"Chen","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.bmc.2024.117933_b0275","doi-asserted-by":"crossref","first-page":"13605","DOI":"10.1038\/srep13605","article-title":"Hypoxia-induced carbonic anhydrase IX facilitates lactate flux in human breast cancer cells by non-catalytic function","volume":"5","author":"Jamali","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2024.117933_b0280","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0076-6879(07)35015-5","article-title":"Tumor hypoxia in cancer therapy","volume":"435","author":"Brown","year":"2007","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.bmc.2024.117933_b0285","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.bmc.2024.117933_b0290","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1126\/science.68.1767.437","article-title":"The chemical constitution of respiration ferment","volume":"68","author":"Warburg","year":"1928","journal-title":"Science"},{"key":"10.1016\/j.bmc.2024.117933_b0295","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1590\/S0100-879X2003000200002","article-title":"Glutamine and glutamate as vital metabolites","volume":"36","author":"Newsholme","year":"2003","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.bmc.2024.117933_b0300","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmc.2024.117933_b0305","doi-asserted-by":"crossref","unstructured":"Brekke E, et al., Anaplerosis for glutamate synthesis in the neonate and in adulthood. The Glutamate\/GABA-Glutamine Cycle: Amino Acid Neurotransmitter Homeostasis; 2016. p. 43\u201358.","DOI":"10.1007\/978-3-319-45096-4_3"},{"key":"10.1016\/j.bmc.2024.117933_b0310","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","article-title":"Cellular fatty acid metabolism and cancer","volume":"18","author":"Currie","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.bmc.2024.117933_b0315","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrc3110","article-title":"Dysregulated pH: a perfect storm for cancer progression","volume":"11","author":"Webb","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmc.2024.117933_b0320","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1113\/jphysiol.2007.145185","article-title":"pH dependence of melanoma cell migration: protons extruded by NHE1 dominate protons of the bulk solution","volume":"585","author":"St\u00fcwe","year":"2007","journal-title":"J Physiol"},{"key":"10.1016\/j.bmc.2024.117933_b0325","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/jmri.10181","article-title":"MRI of the tumor microenvironment","volume":"16","author":"Gillies","year":"2002","journal-title":"J Magn Reson Imag: Off J Int Soc Magn Reson Med"},{"key":"10.1016\/j.bmc.2024.117933_b0330","doi-asserted-by":"crossref","DOI":"10.1039\/D3CP05846H","article-title":"Discovery of non-sulfonamides carbonic anhydrase IX inhibitors through structure-based virtual screening","author":"Cheng","year":"2024","journal-title":"PCCP"},{"key":"10.1016\/j.bmc.2024.117933_b0335","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrc3064","article-title":"Targeting hypoxia in cancer therapy","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmc.2024.117933_b0340","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/biology3030623","article-title":"The structural and functional coordination of glycolytic enzymes in muscle: evidence of a metabolon?","volume":"3","author":"Menard","year":"2014","journal-title":"Biology"},{"key":"10.1016\/j.bmc.2024.117933_b0345","first-page":"3900","article-title":"Characterization of glycolytic enzyme interactions with murine erythrocyte membranes in wild-type and membrane protein knockout mice","volume":"112","author":"Campanella","year":"2008","journal-title":"Blood J Am Soc Hematol"},{"key":"10.1016\/j.bmc.2024.117933_b0350","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrd3745","article-title":"Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma","volume":"11","author":"Zhang","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmc.2024.117933_b0355","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1517\/13543776.2013.794788","article-title":"Antiglaucoma carbonic anhydrase inhibitors: a patent review","volume":"23","author":"Masini","year":"2013","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bmc.2024.117933_b0360","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1517\/13543776.2012.649006","article-title":"Novel therapies for glaucoma: a patent review 2007\u20132011","volume":"22","author":"Carta","year":"2012","journal-title":"Exp Opin Ther Pat"},{"key":"10.1016\/j.bmc.2024.117933_b0365","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5935\/0034-7280.20180002","article-title":"Clinical and epidemiological study in patients with primary open-angle glaucoma","volume":"77","author":"Ribeiro","year":"2018","journal-title":"Rev Bras Oftalmol"},{"key":"10.1016\/j.bmc.2024.117933_b0370","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.3390\/molecules20045667","article-title":"Nitric oxide donors and selective carbonic anhydrase inhibitors: a dual pharmacological approach for the treatment of glaucoma, cancer and osteoporosis","volume":"20","author":"Carradori","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2024.117933_b0375","first-page":"349","article-title":"Glaucoma and the applications of carbonic anhydrase inhibitors","author":"Scozzafava","year":"2014","journal-title":"Carbon Anhydr: Mech Regul Links Disease Ind Appl"},{"key":"10.1016\/j.bmc.2024.117933_b0380","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1167\/iovs.08-2487","article-title":"Studies on bicarbonate transporters and carbonic anhydrase in porcine nonpigmented ciliary epithelium","volume":"50","author":"Shahidullah","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.bmc.2024.117933_b0385","doi-asserted-by":"crossref","first-page":"2335927","DOI":"10.1080\/14756366.2024.2335927","article-title":"Synthesis, carbonic anhydrase inhibition studies and modelling investigations of phthalimide\u2013hydantoin hybrids","volume":"39","author":"Abdoli","year":"2024","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0390","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2174\/156802607780636735","article-title":"The development of topically acting carbonic anhydrase inhibitors as antiglaucoma agents","volume":"7","author":"Mincione","year":"2007","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0395","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1350-9462(99)00006-3","article-title":"Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors","volume":"19","author":"Sugrue","year":"2000","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.bmc.2024.117933_b0400","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nm1534","article-title":"Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation","volume":"13","author":"Gao","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.bmc.2024.117933_b0405","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/jmg.40.4.257","article-title":"Expression of cell surface transmembrane carbonic anhydrase genes CA9 and CA12 in the human eye: overexpression of CA12 (CAXII) in glaucoma","volume":"40","author":"Liao","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/j.bmc.2024.117933_b0410","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1016\/j.bmcl.2004.07.087","article-title":"Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic\/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1, 2, 4-triazine moieties","volume":"14","author":"Garaj","year":"2004","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.117933_b0415","doi-asserted-by":"crossref","first-page":"2291336","DOI":"10.1080\/14756366.2023.2291336","article-title":"Acetazolamide and human carbonic anhydrases: retrospect, review and discussion of an intimate relationship","volume":"39","author":"Tsikas","year":"2024","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0420","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0039-6257(97)00053-2","article-title":"Dorzolamide: development and clinical application of a topical carbonic anhydrase inhibitor","volume":"42","author":"Pfeiffer","year":"1997","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.bmc.2024.117933_b0425","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1021\/jm9900523","article-title":"Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic\/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?","volume":"42","author":"Scozzafava","year":"1999","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0430","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1183\/09031936.98.12061242","article-title":"Carbonic anhydrase inhibitors and ventilation: a complex interplay of stimulation and suppression","volume":"12","author":"Swenson","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.bmc.2024.117933_b0435","first-page":"742","article-title":"Acute mountain sickness and ascent rates in trekkers above 2500 m in the Nepali Himalaya","volume":"77","author":"Vardy","year":"2006","journal-title":"Aviat Space Environ Med"},{"key":"10.1016\/j.bmc.2024.117933_b0440","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/med.21713","article-title":"Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: Where are we today?","volume":"40","author":"Mishra","year":"2020","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmc.2024.117933_b0445","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1055\/s-2007-1024597","article-title":"Acetazolamide and high altitude diseases","volume":"13","author":"Bradwell","year":"1992","journal-title":"Int J Sports Med"},{"key":"10.1016\/j.bmc.2024.117933_b0450","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.resp.2013.05.020","article-title":"Breathing and sleep at high altitude","volume":"188","author":"Ainslie","year":"2013","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.bmc.2024.117933_b0455","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7326\/0003-4819-141-10-200411160-00010","article-title":"The physiologic basis of high-altitude diseases","volume":"141","author":"West","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bmc.2024.117933_b0460","first-page":"6656","article-title":"Acetazolamide pre-treatment before ascending to high altitudes: sustained effect on systemic blood pressure during submaximal exercise","volume":"9","author":"Burtscher","year":"2016","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.bmc.2024.117933_b0465","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/art.27425","article-title":"Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955\u20132007","volume":"62","author":"Myasoedova","year":"2010","journal-title":"Arthrit Rheum"},{"key":"10.1016\/j.bmc.2024.117933_b0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2474-11-279","article-title":"Increased expression of carbonic anhydrase I in the synovium of patients with ankylosing spondylitis","volume":"11","author":"Chang","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.bmc.2024.117933_b0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2474-13-256","article-title":"Transgenic mice over-expressing carbonic anhydrase I showed aggravated joint inflammation and tissue destruction","volume":"13","author":"Zheng","year":"2012","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.bmc.2024.117933_b0480","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/14756366.2016.1217857","article-title":"Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium","volume":"31","author":"Margheri","year":"2016","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0485","first-page":"1","article-title":"Epidemiology of osteoporosis","author":"Becker","year":"2008","journal-title":"Balloon Kyphoplasty"},{"key":"10.1016\/j.bmc.2024.117933_b0490","first-page":"277","article-title":"Carbonic anhydrase activity in fetal rat bone resorbing cells: inhibition by acetazolamide infusion","volume":"12","author":"Hott","year":"1989","journal-title":"J Dev Physiol"},{"key":"10.1016\/j.bmc.2024.117933_b0495","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1079857","article-title":"Obesity and the environment: where do we go from here?","volume":"299","author":"Hill","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bmc.2024.117933_b0500","first-page":"S76","article-title":"The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications","volume":"19","author":"JP","year":"1995","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.bmc.2024.117933_b0505","first-page":"205","article-title":"Effects of obesity on cardiovascular system and blood pressure control, digestive disease and cancer","author":"Van Gaal","year":"1998","journal-title":"Clinical obesity\/Kopelman, P.[edit.]."},{"key":"10.1016\/j.bmc.2024.117933_b0510","doi-asserted-by":"crossref","DOI":"10.3310\/hta8210","article-title":"Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement","volume":"8","author":"Avenell","year":"2004","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.bmc.2024.117933_b0515","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1126\/science.280.5368.1383","article-title":"Strategies and potential molecular targets for obesity treatment","volume":"280","author":"Campfield","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bmc.2024.117933_b0520","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00228-006-0186-z","article-title":"Current and novel approaches to the drug therapy of obesity","volume":"62","author":"Chaput","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.bmc.2024.117933_b0525","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1152\/jappl.1987.63.5.2134","article-title":"Inhibition of mitochondrial carbonic anhydrase and ureagenesis: a discrepancy examined","volume":"63","author":"Dodgson","year":"1987","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.bmc.2024.117933_b0530","unstructured":"Citriniti EL, et al. Discover the Power of Lithospermic Acid as Human Carbonic Anhydrase Va and Pancreatic Lipase Inhibitor Through in Silico and in Vitro Studies. Claudiu T. and Alcaro, Stefano and Ortuso, Francesco, Discover the Power of Lithospermic Acid as Human Carbonic Anhydrase Va and Pancreatic Lipase Inhibitor Through in Silico and in Vitro Studies."},{"key":"10.1016\/j.bmc.2024.117933_b0535","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1096\/fasebj.10.4.8647347","article-title":"Differentiation-dependent expression of CA V and the role of carbonic anhydrase isozymes in pyruvate carboxylation in adipocytes","volume":"10","author":"Hazen","year":"1996","journal-title":"FASEB J"},{"key":"10.1016\/j.bmc.2024.117933_b0540","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0163-7827(96)00010-0","article-title":"Short-term regulation of acetyl CoA carboxylase in tissues of higher animals","volume":"35","author":"Allred","year":"1996","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.bmc.2024.117933_b0545","doi-asserted-by":"crossref","first-page":"968a","DOI":"10.1176\/ajp.156.6.968a","article-title":"Mood stabilization and weight loss with topiramate","volume":"156","author":"Gordon","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bmc.2024.117933_b0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2024.109381","article-title":"An asiatic acid derived trisulfamate acts as a nanomolar inhibitor of human carbonic anhydrase VA","author":"Denner","year":"2024","journal-title":"Steroids"},{"key":"10.1016\/j.bmc.2024.117933_b0555","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.2174\/1381612822666160226144200","article-title":"Polypharmacological drugs in the treatment of epilepsy: the comprehensive review of marketed and new emerging molecules","volume":"22","author":"Kumari","year":"2016","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bmc.2024.117933_b0560","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1038\/emboj.2013.160","article-title":"Neuronal carbonic anhydrase VII provides GABAergic excitatory drive to exacerbate febrile seizures","volume":"32","author":"Ruusuvuori","year":"2013","journal-title":"EMBO J"},{"key":"10.1016\/j.bmc.2024.117933_b0565","doi-asserted-by":"crossref","unstructured":"Ruusuvuori E, Kaila K. Carbonic anhydrases and brain pH in the control of neuronal excitability. Carbonic anhydrase: mechanism, regulation, links to disease, and industrial applications 2014: 271\u2013290.","DOI":"10.1007\/978-94-007-7359-2_14"},{"key":"10.1016\/j.bmc.2024.117933_b0570","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1046\/j.1471-4159.2000.0752212.x","article-title":"Mitochondrial carbonic anhydrase in the nervous system: expression in neuronal and glial cells","volume":"75","author":"Ghandour","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.bmc.2024.117933_b0575","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/106002809603000515","article-title":"Acetazolamide in the treatment of seizures","volume":"30","author":"Reiss","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.bmc.2024.117933_b0580","doi-asserted-by":"crossref","unstructured":"Eckert DJ, et al. Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets. Am J Respir Crit Care Med 2013; 188: 996\u20131004.","DOI":"10.1164\/rccm.201303-0448OC"},{"key":"10.1016\/j.bmc.2024.117933_b0585","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1183\/09031936.00.16592100","article-title":"Therapy with nCPAP: incomplete elimination of sleep related breathing disorder","volume":"16","author":"Grote","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.bmc.2024.117933_b0590","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1183\/09031936.03.00113102","article-title":"Theophylline and acetazolamide reduce sleep-disordered breathing at high altitude","volume":"23","author":"Fischer","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.bmc.2024.117933_b0595","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1515\/CCLM.2009.102","article-title":"Elevated erythrocyte carbonic anhydrase activity is a novel clinical marker in hyperventilation syndrome","volume":"47","author":"Teng","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.bmc.2024.117933_b0600","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1113\/jphysiol.2011.223925","article-title":"Acetazolamide improves loop gain but not the other physiological traits causing obstructive sleep apnoea","volume":"590","author":"Edwards","year":"2012","journal-title":"J Physiol"},{"key":"10.1016\/j.bmc.2024.117933_b0605","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0034-5687(91)90104-Q","article-title":"Renal carbonic anhydrase inhibition reduces high altitude sleep periodic breathing","volume":"86","author":"Swenson","year":"1991","journal-title":"Respir Physiol"},{"key":"10.1016\/j.bmc.2024.117933_b0610","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1164\/rccm.200507-1035OC","article-title":"Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study","volume":"173","author":"Javaheri","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.bmc.2024.117933_b0615","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/13543784.2021.2014813","article-title":"Carbonic anhydrase inhibitors: an update on experimental agents for the treatment and imaging of hypoxic tumors","volume":"30","author":"Supuran","year":"2021","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.bmc.2024.117933_b0620","article-title":"Therapeutic potential of carbonic anhydrase inhibitors","volume":"32","author":"Bibi","year":"2019","journal-title":"Pak J Pharm Sci"},{"key":"10.1016\/j.bmc.2024.117933_b0625","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.4155\/fmc.14.68","article-title":"Sulfonamides and their isosters as carbonic anhydrase inhibitors","volume":"6","author":"Carta","year":"2014","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0630","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3390\/ijms17071150","article-title":"Non-classical inhibition of carbonic anhydrase","volume":"17","author":"Lomelino","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2024.117933_b0635","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.21930","article-title":"Inhibition properties of some flavonoids on carbonic anhydrase I and II isoenzymes purified from human erythrocytes","volume":"31","author":"Huyut","year":"2017","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.bmc.2024.117933_b0640","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1080\/14756366.2020.1788009","article-title":"Coumarin carbonic anhydrase inhibitors from natural sources","volume":"35","author":"Supuran","year":"2020","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0645","doi-asserted-by":"crossref","first-page":"6505","DOI":"10.1016\/j.bmcl.2008.10.047","article-title":"Novel anthraquinone derivatives: Synthesis via click chemistry approach and their induction of apoptosis in BGC gastric cancer cells via reactive oxygen species (ROS)-dependent mitochondrial pathway","volume":"18","author":"Wang","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.117933_b0650","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1080\/14756366.2022.2056733","article-title":"5-(Sulfamoyl) thien-2-yl 1, 3-oxazole inhibitors of carbonic anhydrase II with hydrophilic periphery","volume":"37","author":"Kalinin","year":"2022","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105764","article-title":"Tail-approach based design and synthesis of Arylthiazolylhydrazono-1, 2, 3-triazoles incorporating sulfanilamide and metanilamide as human carbonic anhydrase I, II, IV and IX inhibitors","volume":"123","author":"Kumar","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0660","doi-asserted-by":"crossref","first-page":"6965","DOI":"10.1080\/07391102.2021.1892527","article-title":"Investigation of in vitro and in silico effects of some novel carbazole Schiff bases on human carbonic anhydrase isoforms I and II","volume":"40","author":"Camadan","year":"2022","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmc.2024.117933_b0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112219","article-title":"Tail approach synthesis of novel benzenesulfonamides incorporating 1, 3, 4-oxadiazole hybrids as potent inhibitor of carbonic anhydrase I, II, IX, and XII isoenzymes","volume":"193","author":"Sharma","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103839","article-title":"Synthesis and carbonic anhydrase inhibition studies of sulfonamide based indole-1, 2, 3-triazole chalcone hybrids","volume":"99","author":"Singh","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0675","doi-asserted-by":"crossref","first-page":"2000230","DOI":"10.1002\/ardp.202000230","article-title":"Synthesis of benzamide derivatives with thiourea-substituted benzenesulfonamides as carbonic anhydrase inhibitors","volume":"354","author":"Tugrak","year":"2021","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bmc.2024.117933_b0680","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/14756366.2019.1700240","article-title":"Novel sulphonamides incorporating triazene moieties show powerful carbonic anhydrase I and II inhibitory properties","volume":"35","author":"Bilginer","year":"2020","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0685","doi-asserted-by":"crossref","unstructured":"Akocak S. et al., Novel 1, 3-diaryltriazene-substituted sulfaguanidine derivatives as selective carbonic anhydrase inhibitors: synthesis, characterization, inhibition effects, and molecular docking studies. 2023.","DOI":"10.21203\/rs.3.rs-2812331\/v1"},{"key":"10.1016\/j.bmc.2024.117933_b0690","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1021\/acs.jmedchem.3c02279","article-title":"Discovery of novel pyridazine-tethered sulfonamides as carbonic anhydrase II inhibitors for the management of glaucoma","volume":"67","author":"Tawfik","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0695","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1080\/14756366.2017.1380638","article-title":"Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors","volume":"32","author":"Ramya","year":"2017","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112392","article-title":"Synthesis, characterization and carbonic anhydrase I and II inhibitory evaluation of new sulfonamide derivatives bearing dithiocarbamate","volume":"198","author":"Sa\u011fl\u0131k","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0705","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ejmech.2017.01.017","article-title":"Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies","volume":"127","author":"Eldehna","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.137365","article-title":"New naphthoquinone thiazole hybrids as carbonic anhydrase and cholinesterase inhibitors: synthesis, crystal structure, molecular docking, and acid dissociation constant","volume":"1301","author":"Efeoglu","year":"2024","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2024.117933_b0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111811","article-title":"Direct and straightforward access to substituted alkyl selenols as novel carbonic anhydrase inhibitors","volume":"185","author":"Tanini","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0720","doi-asserted-by":"crossref","first-page":"2100476","DOI":"10.1002\/ardp.202100476","article-title":"Some phenolic natural compounds as carbonic anhydrase inhibitors: an in vitro and in silico study","volume":"355","author":"Aggul","year":"2022","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bmc.2024.117933_b0725","first-page":"1","article-title":"A novel class of phenylpyrazolone-sulphonamides rigid synthetic anticancer molecules selectively inhibit the isoform IX of carbonic anhydrases guided by molecular docking and orbital analyses","author":"Khayat","year":"2023","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmc.2024.117933_b0730","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129479","article-title":"Potent and selective carbonic anhydrase inhibition activities of pyrazolones bearing benzenesulfonamides","volume":"95","author":"Akocak","year":"2023","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.117933_b0735","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114004","article-title":"Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine-Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors","volume":"228","author":"Abdel-Mohsen","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.107089","article-title":"Identification of thienopyrimidine derivatives tethered with sulfonamide and other moieties as carbonic anhydrase inhibitors: design, synthesis and anti-proliferative activity","volume":"144","author":"Higazy","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116527","article-title":"A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessments","author":"Hefny","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128249","article-title":"Novel triazole-sulfonamide bearing pyrimidine moieties with carbonic anhydrase inhibitory action: design, synthesis, computational and enzyme inhibition studies","volume":"48","author":"Manzoor","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.117933_b0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131145","article-title":"Designing novel anticancer sulfonamide based 2, 5-disubstituted-1, 3, 4-thiadiazole derivatives as potential carbonic anhydrase inhibitor","volume":"1246","author":"Abas","year":"2021","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2024.117933_b0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115805","article-title":"Exploring novel anticancer pyrazole benzenesulfonamides featuring tail approach strategy as carbonic anhydrase inhibitors","author":"Ahmed","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.128966","article-title":"Novel adamantane-pyrazole and hydrazone hybridized: design, synthesis, cytotoxic evaluation, SAR study and molecular docking simulation as carbonic anhydrase inhibitors","volume":"1223","author":"Wassel","year":"2021","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2024.117933_b0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113283","article-title":"Development of novel benzofuran-based SLC-0111 analogs as selective cancer-associated carbonic anhydrase isoform IX inhibitors","volume":"216","author":"Shaldam","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.128259","article-title":"Synthesis of new class of non-sulfonamide bis-benzimidazoles as antitumor agents by inhibiting carbonic anhydrase-IX enzyme","volume":"255","author":"Khan","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.bmc.2024.117933_b0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128809","article-title":"Synthesis of a new series of quinoline\/pyridine indole-3-sulfonamide hybrids as selective carbonic anhydrase IX inhibitors","volume":"70","author":"Singh","year":"2022","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.117933_b0785","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1021\/acsomega.2c07459","article-title":"Tail-approach-based design and synthesis of coumarin-monoterpenes as carbonic anhydrase inhibitors and anticancer agents","volume":"8","author":"Zengin Kurt","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmc.2024.117933_b0790","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1080\/14756366.2020.1712596","article-title":"Sulfocoumarins as dual inhibitors of human carbonic anhydrase isoforms IX\/XII and of human thioredoxin reductase","volume":"35","author":"Krasavin","year":"2020","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114811","article-title":"Carbonic Anhydrase inhibitors bearing organotelluride moieties as novel agents for antitumor therapy","volume":"244","author":"Petreni","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107192","article-title":"A comparative study of diaryl urea molecules with and without sulfonamide group on Carbonic anhydrase IX and XII inhibition and its consequence on breast cancer cells","volume":"145","author":"Debnath","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0805","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.3390\/ijms25063348","article-title":"Novel anthraquinone-based benzenesulfonamide derivatives and their analogues as potent human carbonic anhydrase inhibitors with antitumor activity: synthesis, biological evaluation, and in silico analysis","volume":"25","author":"Wu","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2024.117933_b0810","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ajhg.2014.01.006","article-title":"Mitochondrial carbonic anhydrase VA deficiency resulting from CA5A alterations presents with hyperammonemia in early childhood","volume":"94","author":"van Karnebeek","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bmc.2024.117933_b0815","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bmc.2009.11.021","article-title":"Carbonic anhydrase inhibitors. Identification of selective inhibitors of the human mitochondrial isozymes VA and VB over the cytosolic isozymes I and II from a natural product-based phenolic library","volume":"18","author":"Davis","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103896","article-title":"N-aryl-N\u2032-ureido-O-sulfamates as potent and selective inhibitors of hCA VB over hCA VA: deciphering the binding mode of new potential agents in mitochondrial dysfunctions","volume":"100","author":"Poli","year":"2020","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0825","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1021\/acs.jmedchem.0c01889","article-title":"Discovery of potent carbonic anhydrase inhibitors as effective anticonvulsant agents: drug design, synthesis, and in vitro and in vivo investigations","volume":"64","author":"Mishra","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117933_b0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135047","article-title":"Structural characterization and biological evaluation of uracil-appended benzylic amines as acetylcholinesterase and carbonic anhydrase I and II inhibitors","volume":"1280","author":"Bulut","year":"2023","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2024.117933_b0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131927","article-title":"The effect of benzenesulfonamide's side chains on their human carbonic anhydrase \u2160\/\u2161 inhibitory activities","volume":"1250","author":"Yang","year":"2022","journal-title":"J Mol Struct"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808962400347X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808962400347X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T12:34:55Z","timestamp":1730378095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096808962400347X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":167,"alternative-id":["S096808962400347X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117933","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carbonic anhydrases: Moiety appended derivatives, medicinal and pharmacological implications","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117933","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117933"}}